PortfoliosLab logoPortfoliosLab logo
HMY vs. ZVRA
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

HMY vs. ZVRA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Harmony Gold Mining Company Limited (HMY) and Zevra Therapeutics Inc. (ZVRA). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, HMY achieves a -19.33% return, which is significantly lower than ZVRA's 6.14% return. Over the past 10 years, HMY has outperformed ZVRA with an annualized return of 14.12%, while ZVRA has yielded a comparatively lower -17.62% annualized return.


HMY

1D
-2.48%
1M
3.75%
6M
-24.77%
YTD
-19.33%
1Y
19.86%
3Y*
60.02%
5Y*
32.73%
10Y*
14.12%
ALL TIME*
3.26%

ZVRA

1D
-1.35%
1M
-31.14%
6M
5.67%
YTD
6.14%
1Y
-14.40%
3Y*
24.74%
5Y*
-1.18%
10Y*
-17.62%
ALL TIME*
-23.23%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$40.27M$46.42M$65.95M
$18.33M$18.68M$21.76M

HMY vs. ZVRA - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
HMY
Harmony Gold Mining Company Limited
-19.33%145.47%35.39%82.51%-16.42%-10.25%28.93%102.79%-4.28%-12.94%
ZVRA
Zevra Therapeutics Inc.
6.14%7.43%27.33%42.70%-47.30%-22.23%84.70%-78.71%-56.05%37.29%

Correlation

The correlation between HMY and ZVRA is 0.11, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.11

Correlation (3Y)
Balances recent behavior with more history.

0.09

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.08

Correlation (10Y)
Provides a long-term view across more market conditions.

0.06

Correlation (All Time)
Calculated using the full available price history since Apr 16, 2015

0.05

Fundamentals

Market Cap

HMY:

$9.94B

ZVRA:

$562.18M

EPS

HMY:

ZAR 41.67

ZVRA:

$2.15

PE Ratio

HMY:

6.24

ZVRA:

4.43

PS Ratio

HMY:

1.09

ZVRA:

4.50

PB Ratio

HMY:

3.17

ZVRA:

2.78

Total Revenue (TTM)

HMY:

ZAR 150.28B

ZVRA:

$122.29M

Gross Profit (TTM)

HMY:

ZAR 57.55B

ZVRA:

$104.94M

EBITDA (TTM)

HMY:

ZAR 55.56B

ZVRA:

$149.15M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

HMY vs. ZVRA — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

HMY
HMY Risk / Return Rank: 5656
Overall Rank
HMY Sharpe Ratio Rank: 5656
Sharpe Ratio Rank
HMY Sortino Ratio Rank: 5656
Sortino Ratio Rank
HMY Omega Ratio Rank: 5555
Omega Ratio Rank
HMY Calmar Ratio Rank: 5555
Calmar Ratio Rank
HMY Martin Ratio Rank: 5555
Martin Ratio Rank

ZVRA
ZVRA Risk / Return Rank: 3434
Overall Rank
ZVRA Sharpe Ratio Rank: 3434
Sharpe Ratio Rank
ZVRA Sortino Ratio Rank: 3636
Sortino Ratio Rank
ZVRA Omega Ratio Rank: 3737
Omega Ratio Rank
ZVRA Calmar Ratio Rank: 3232
Calmar Ratio Rank
ZVRA Martin Ratio Rank: 3131
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

HMY vs. ZVRA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Harmony Gold Mining Company Limited (HMY) and Zevra Therapeutics Inc. (ZVRA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


HMYZVRADifference
Sharpe ratioReturn per unit of total volatility

+0.52

Sortino ratioReturn per unit of downside risk

+0.74

Omega ratioGain probability vs. loss probability

1.11

1.02

+0.09

Calmar ratioReturn relative to maximum drawdown

0.41

-0.36

+0.77

Martin ratioReturn relative to average drawdown

0.76

-0.65

+1.41

HMY vs. ZVRA - Sharpe Ratio Comparison

The current HMY Sharpe Ratio is 0.30, which is higher than the ZVRA Sharpe Ratio of -0.22. The chart below compares the historical Sharpe Ratios of HMY and ZVRA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

HMY vs. ZVRA - Drawdown Comparison

The maximum HMY drawdown since its inception was -97.04%, roughly equal to the maximum ZVRA drawdown of -99.27%. Use the drawdown chart below to compare losses from any high point for HMY and ZVRA.


Loading charts...

Drawdown Indicators


HMYZVRADifference

Max Drawdown

Largest peak-to-trough decline

-97.04%

-99.27%

+2.23%

Max Drawdown (1Y)

Largest decline over 1 year

-48.85%

-40.40%

-8.45%

Max Drawdown (3Y)

Largest decline over 3 years

-48.85%

-43.47%

-5.38%

Max Drawdown (5Y)

Largest decline over 5 years

-62.48%

-60.97%

-1.51%

Max Drawdown (10Y)

Largest decline over 10 years

-71.05%

-97.85%

+26.80%

Current Drawdown

Current decline from peak

-38.35%

-97.48%

+59.13%

Average Drawdown

Average peak-to-trough decline

-52.68%

-86.53%

+33.85%

Ulcer Index

Depth and duration of drawdowns from previous peaks

26.05%

22.22%

+3.83%

Volatility

HMY vs. ZVRA - Volatility Comparison

The current volatility for Harmony Gold Mining Company Limited (HMY) is 15.77%, while Zevra Therapeutics Inc. (ZVRA) has a volatility of 29.44%. This indicates that HMY experiences smaller price fluctuations and is considered to be less risky than ZVRA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


HMYZVRADifference

Volatility (1M)

Calculated over the trailing 1-month period

15.77%

29.44%

-13.67%

Volatility (6M)

Calculated over the trailing 6-month period

49.41%

49.17%

+0.24%

Volatility (1Y)

Calculated over the trailing 1-year period

66.55%

65.35%

+1.20%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

59.01%

61.11%

-2.10%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

60.90%

81.05%

-20.15%

Dividends

HMY vs. ZVRA - Dividend Comparison

HMY's dividend yield for the trailing twelve months is around 2.55%, while ZVRA has not paid dividends to shareholders.


PositionTTM2025202420232022202120202019201820172016
HMY
Harmony Gold Mining Company Limited
2.55%1.07%1.59%0.66%1.14%2.23%0.00%0.00%0.00%3.13%1.37%
ZVRA
Zevra Therapeutics Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

HMY vs. ZVRA - Financials Comparison

This section allows you to compare key financial metrics between Harmony Gold Mining Company Limited and Zevra Therapeutics Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


HMY and ZVRA have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ZVRA has higher volatility (29.44%) compared to HMY (15.77%). In terms of maximum drawdown, HMY dropped -97.04% vs ZVRA's -99.27%.

HMY currently has the higher Sharpe Ratio (0.30 vs -0.22), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for HMY and ZVRA

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer